Adaptive AI for Multiple Health Environments

Physician Practice Groups

Community & Safety-Net Providers

FQHCs

Hospital Systems

PACE Organizations

Specialized Care Models

– Large Regional IDNs

– Multi-Specialty Groups

– Mid-Size Systems

– Independent Groups

Hospital Systems

WellBridge delivers a 5-7x pharmacist productivity multiplier through agentic AI workflow automation that delivers care insights in the workflow, enabling Large Regional IDNs to address capacity constraints without adding FTEs.

The WellBridge Difference

WellBridge enables Large Regional IDNs to capture Millions in incremental annual quality bonuses through 0.5-1.0 Star Rating improvements on medication and pharmacy-related measures while achieving 30%+ pharmacist time savings per review.

Common Pain Points

Large Regional IDNs face a critical capacity crisis as CMS MTM expansion doubles their eligible population amid severe pharmacist shortages, putting Millions in Star Ratings revenue at risk. To address these challenges, IDNs will need to uplevel clinical workflows and standardize medication management across multiple facilities while monitoring ongoing care gap closure to maximize savings opportunities.

Turn Medication Optimization Into Your Strategic Advantage

Large Regional IDN

WellBridge workflows drive upwards of 40% medication adherence (PDC) improvements, CMR/MTM, Poly-ACH quality measure capture and reduce medication-related readmissions by 22%, delivering measurable clinical and financial outcomes across the enterprise.

WellBridge provides system-wide standardization with local customization flexibility and EHR-integrated workflows (Epic/Cerner/Athena/ECW/Meditech), backed by a proven pilot-to-scale playbook from comparable regional IDNs.

Medication management platform built for mid-size regional systems: reduce avoidable utilization, lift quality performance, and extend pharmacist reach, without major IT projects or adding headcount

IDN-Level Clinical Impact With Mid-Market Resourcing

The WellBridge Difference

WellBridge removes the barriers that typically slow mid-market adoption with a turnkey quality improvement program that can be implemented in 60-90 days and imposes minimal IT burden. Success-based pricing options, coupled with vendor-led change management, reduce upfront financial risk while minimizing burdens on internal teams that are already stretched thin.

With WellBridge as your trusted ally, Mid-Sized systems are positioned to:

Common Pain Points

Mid-Size Systems (4 to 9 facilities) face the same CMS MTM expansion pressure as large IDNs but with significantly fewer resources, putting revenues derived from Star Ratings ($500K to $1.5M) at risk. Competition with larger health and academic medical centers for clinical pharmacy talent further compounds the impact of the pharmacist workforce shortage.

Mid-Size System

Realize +30% savings in pharmacists’ time and productivity, enabling capacity expansion and +5% point PDC improvements.

Capture $500K-1.5M in annual quality bonuses while achieving 20%+ MTM completion rate improvements within 3 months of single-site pilots.

Physician Practice Groups

AI-powered pharmacist platform that standardizes medication management across all specialties—improving quality scores 10-15%, driving medication-related care coordination resulting in $500K-2M in savings and freeing 3-5 hours/week of PCP time.

The WellBridge Difference

WellBridge enables Multi-Specialty provider groups to identify and understand which medications drive outcomes, by specialty, and act on those insights at the point of care. Our platform attributes medication impact across cardiology, endocrinology, and oncology and converts those insights into specialty-specific, guideline-aligned recommendations delivered within existing EHR workflows. Physicians can review and approve actions in 2–3 minutes, preserving visit efficiency.

WellBridge supports clinical judgment and specialty complexity, enabling:

Common Pain Points

Multi-Specialty Groups leave $500K+ in value-based incentives uncaptured due to fragmented accountability across specialties and lack of a standard MTM operating model, with CMR completion rates varying widely from 20-80%. Primary care capacity constraints force reactive year-end quality sprints while data plumbing limitations prevent proactive patient identification, and high-cost specialty drugs create P&T operationalization gaps that increase waste.

Capture ACO Shared Savings Left on the Table

Multi-Specialty and Independent Groups

Standardized workflows that adapt to each specialty's practice patterns rather than imposing uniform treatment rules.

Care coordination insights deliver $500K to $2M in savings and free 3-5 hours per week of PCP time for direct patient care, while multiplying embedded pharmacist capacity by 5-7x.

Capture of +$500K in previously uncaptured ACO shared savings while achieving 10-15% quality score improvement within 90 days.

Pharmacist-led MTM platform purpose-built for FQHCs: Close UDS quality gaps, optimize 340B revenue, and multiply PCP capacity in 90-120 days—without complex EHR builds or adding staff.

The WellBridge Difference

WellBridge offers OCHIN-compatible deployment with pre-built hosted Epic integrations and automated UDS+ reporting that generates auditable MTM artifacts, delivering 90-120 day ROI that aligns with grant reporting cycles. Our platform optimizes 340B programs through formulary alignment and adherence, advancing the mission of health equity and improved patient outcomes.

With proven results across OCHIN and Health Center Controlled Networks serving 300+ community health centers, WellBridge enables FQHCs to:

Common Pain Points

FQHCs operate on razor-thin margins (1-3%) while facing 340B revenue volatility of $500K-2M and persistent UDS quality measure gaps that threaten HRSA grant renewals. They manage 1,800-2,500 patient panels per PCP with severe primary care and behavioral health capacity constraints, while 15-25% of ED visits are medication-related and avoidable, and hosted EHR integration constraints and UDS+ reporting burden compound operational challenges.

Community and Safety-Net Providers

Turn UDS Quality Gaps Into Grant-Securing Strengths

Federally Qualified Health Centers (FQHC)

Reduce avoidable ED visits by 15-20% and free 3-5 hours per week of PCP time for patient care.

Protect $200K-500K in HRSA grant funding through UDS improvements and capture $100K-500K in Medicaid managed care quality bonuses, while achieving 10-15% improvements in A1c and blood pressure control measures.

Specialized Care Models

Reduce medication-related hospitalizations, lower pharmacy spend by 8%+, and scale clinical pharmacist capacity across all your centers—without adding FTEs. Purpose-built for PACE interdisciplinary teams managing complex, at-risk participants who need to stay safely at home.

The WellBridge Difference

WellBridge delivers clinical pharmacist expertise at enterprise scale, preventing medication crises before they send participants to the hospital. Our InsightsRX platform integrates seamlessly into your EMR workflow, automatically identifying medications to deprescribe, high-risk medications, and duplicative medication classes. WellBridge delivers evidence-based recommendations to your interdisciplinary care teams at every touchpoint.

ROI and Value Creation Proof Points

Increase Medication Recommendation Acceptance Driving High-Impact Clinical Interventions

Common Pain Points

Low retention and turnover rates amongst participants as most have 15+ active medications with some as high as 40 and require personalized medication review. New participants opt to dis-enroll when their care isn't personalized to their active medications.

Turn Medication Complexity Into Your Quality, Cost and Participant Retention Advantage

For PACE organizations reducing pharmacy spend by 8%+ while preventing the hospitalizations that threaten contract viability.

Participants on 10+ medications with multiple chronic conditions, high risk for adverse drug events and hospitalizations.

Rising pharmacy claims and medication-related complications driving up total medical cost.

Preventable hospitalizations and ED visits reducing days at home, a critical PACE quality and cost metric.

Clinical pharmacists and interdisciplinary teams stretched thin, managing hundreds of manual medication reviews.

Fragmented data across EMR, pharmacy systems, and analytics platforms—no integrated view of medication risk.

Lower Total Medical Cost through Pharmacy Claims Spend Reductions

Increase Provider Adoption Across Multiple Centers With Immediate Clinical Impact

PACE Organizations